Back to Vistagen Therapeutics, Inc.

Vistagen Therapeutics, Inc.

All insider transactions

1 transactions

DateMoveSecurityInsiderΔ sharesPriceValueHeld afterImpact
Dec 31, 2025Other
Grant / award
Common StockPrince Joshua S.
Executive
+4,386$0.56$2.5K15,249low
← PrevPage 1 of 1Next →